Pan Drugs has informed that a meeting of the Board of Directors of the Company is scheduled to be held on February 13, 2017, to consider and approve the Unaudited Quarterly Financial Results for the quarter (Q3) and nine months ended December 31, 2016. Further pursuant to the provisions of the SEBI (Prohibition of Insider Trading Regulations), 1992 and the Code for Prevention of Insider Trading (Code) of the Company, the trading window for dealing in the Securities of the Company shall remain close for Directors, Officers and Designated Persons, from February 04, 2017 up to 48 Hours after announcement of financial results.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1808.20 |
| Dr. Reddys Lab | 1322.95 |
| Cipla | 1309.90 |
| Zydus Lifesciences | 891.65 |
| Lupin | 2303.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: